US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Alto Neuroscience Inc

36.44

+0.19000.52%

Volume:275.24K

Turnover:10.06M

Market Cap:1.42B

PE:-15.30

High:37.43

Open:36.58

Low:35.74

Close:36.25

52wk High:37.43

52wk Low:3.41

Shares:38.87M

Float Shares:28.30M

Volume Ratio:0.95

T/O Rate:0.97%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.3816

EPS(LYR):-2.1918

ROE:-49.17%

ROA:-26.79%

PB:6.46

PE(LYR):-16.63

Loading ...

Overview Company News Filings

Alto Neuroscience Inc - Topline Data Expected in Second Half of 2027

THOMSON REUTERS

Alto Neuroscience Initiates Phase 2B Trial of Alto-207 in Treatment-Resistant Depression

THOMSON REUTERS

Alto Neuroscience Files for Resale of Shares by Selling Stockholders

MT Newswires Live

BRIEF-Alto Neuroscience - Proposed Resale Of Up To 6 Million Shares Of Common Stock By Selling Stockholders - SEC Filing

Alto Neuroscience - Proposed Resale of up to 6 Mln Shares of Common Stock by Selling Stockholders - SEC Filing

THOMSON REUTERS

Analysts Conflicted on These Healthcare Names: Merck & Company (MRK) and Alto Neuroscience, Inc. (ANRO)

Update: Alto Neuroscience Shares Fall After Phase 2 Trial of ALTO-101 Yields Statistically Insignificant Data

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Alto Neuroscience, Inc. (ANRO)

Alto Neuroscience Is Maintained at Buy by Chardan Capital

Alto Neuroscience, Immunovant And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Wedbush Cuts Price Target on Alto Neuroscience to $21 From $22, Keeps Neutral Rating

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO) and Innovative Eyewear, Inc. (LUCY)

U.S. RESEARCH ROUNDUP-Doordash, Phillips 66, United Therapeutics

Alto Neuroscience Inc : Baird Cuts Target Price to $38 From $41

THOMSON REUTERS

Chardan Capital Remains a Buy on Alto Neuroscience, Inc. (ANRO)

Stocks to Watch: Franklin Covey, Penguin Solutions, Alto Neuroscience

Alto Shifts Focus to ALTO-207 After ALTO-101 Data

Pipeline Strength and Key Late-Stage Assets Drive Upside in Alto Neuroscience Despite ALTO-101 Setback

BRIEF-Alto Neuroscience Reports Topline Data From Phase 2 Proof-Of-Concept Study Of Alto-101 And Highlights Pipeline Advancements

Alto Neuroscience publishes investor presentation on biomarker-driven precision psychiatry pipeline

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/ANRO/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ANRO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANRO\",,,,,undefined,":{"symbol":"ANRO","market":"US","secType":"STK","nameCN":"Alto Neuroscience Inc","latestPrice":36.44,"timestamp":1787679715532,"preClose":36.25,"halted":0,"volume":275237,"delay":0,"changeRate":0.005241379310344765,"floatShares":28296500,"shares":38870376,"eps":-2.381577,"marketStatus":"Trading","change":0.19,"latestTime":"08-25 13:42:09 EDT","open":36.58,"high":37.43,"low":35.74,"amount":10061750.93316,"amplitude":0.046621,"askPrice":36.58,"askSize":265,"bidPrice":36.45,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-2.381577,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"listingDate":1706850000000,"exchange":"NYSE","adjPreClose":36.25,"preHourTrading":{"tag":"盘前","latestPrice":37.02,"preClose":36.25,"latestTime":"09:12 EDT","volume":284,"amount":10404.446784,"timestamp":1787663540793,"change":0.77,"changeRate":0.021241,"amplitude":0.026207},"postHourTrading":{"tag":"盘后","latestPrice":36.5,"preClose":36.25,"latestTime":"19:30 EDT","volume":6925,"amount":251486.4535,"timestamp":1787614204847,"change":0.25,"changeRate":0.006897,"amplitude":0.019862},"volumeRatio":0.945903,"impliedVol":0.786,"impliedVolPercentile":0.3267},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANRO\",,,,,undefined,":{"symbol":"ANRO","floatShares":28296500,"roa":"-26.79%","roe":"-49.17%","lyrEps":-2.191806,"volumeRatio":0.945903,"shares":38870376,"dividePrice":0,"high":37.43,"amplitude":0.046621,"preClose":36.25,"low":35.74,"week52Low":3.41,"pbRate":"6.46","week52High":37.43,"institutionHeld":0,"latestPrice":36.44,"committee":-0.927273,"eps":-2.381577,"divideRate":0,"volume":275237,"delay":0,"ttmEps":-2.381577,"open":36.58,"prevYearClose":17.8,"prevWeekClose":34.28,"prevMonthClose":27.07,"prevQuarterClose":26.39,"fiveDayClose":34.13,"twentyDayClose":27.42,"sixtyDayClose":20.07},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ANRO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"ANRO","fiscalQuarterEnding":"2026/06","expectedEps":-0.71,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.65},{"market":"US","date":"2026-05-13","symbol":"ANRO","fiscalQuarterEnding":"2026/03","expectedEps":-0.56,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"pre","actualEps":-0.8},{"market":"US","date":"2026-03-16","symbol":"ANRO","fiscalQuarterEnding":"2025/12","expectedEps":-0.56,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773633600000,"reportTimeType":"pre","actualEps":-0.45},{"market":"US","date":"2025-11-12","symbol":"ANRO","fiscalQuarterEnding":"2025/09","expectedEps":-0.66,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.52},{"market":"US","date":"2025-08-13","symbol":"ANRO","fiscalQuarterEnding":"2025/06","expectedEps":-0.57,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.65}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ANRO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ANRO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6364,"buy":0.2727,"hold":0.0909,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6364,"analysts":11,"updateTime":1786939200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ANRO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ANRO","date":"2026-08-21","current":-15.221007,"percent":0.003231,"low":-16.978804,"twenty":-10.831771,"median":-6.749002,"eighty":-1.49576,"high":-0.793245,"avg":-6.422904,"sd":4.54375,"marketCap":1344042062},"quantilePoints":[{"date":"2024-02-09","current":-15.481605,"twenty":-16.048587,"median":-15.481605,"eighty":-13.872658,"marketCap":506867732},{"date":"2024-02-16","current":-12.96931,"twenty":-15.548491,"median":-13.234406,"eighty":-11.571235,"marketCap":424615224},{"date":"2024-02-23","current":-10.603839,"twenty":-15.481605,"median":-12.585941,"eighty":-11.026361,"marketCap":347169680},{"date":"2024-03-01","current":-12.56147,"twenty":-14.292343,"median":-12.488059,"eighty":-11.135662,"marketCap":411262544},{"date":"2024-03-08","current":-11.631595,"twenty":-13.230328,"median":-12.361629,"eighty":-11.293904,"marketCap":380818433},{"date":"2024-03-15","current":-12.153631,"twenty":-13.001937,"median":-12.137317,"eighty":-11.306955,"marketCap":397909864},{"date":"2024-03-22","current":-11.14409,"twenty":-12.949734,"median":-12.108768,"eighty":-11.306955,"marketCap":404586204},{"date":"2024-03-28","current":-12.415912,"twenty":-12.956259,"median":-12.145474,"eighty":-11.437463,"marketCap":450759680},{"date":"2024-04-05","current":-10.418119,"twenty":-12.920369,"median":-11.868143,"eighty":-11.162905,"marketCap":378229815},{"date":"2024-04-12","current":-10.440317,"twenty":-12.863272,"median":-11.793418,"eighty":-10.823597,"marketCap":379035702},{"date":"2024-04-19","current":-9.988964,"twenty":-12.713187,"median":-11.631595,"eighty":-10.532067,"marketCap":362649325},{"date":"2024-04-26","current":-10.455115,"twenty":-12.538631,"median":-11.566341,"eighty":-10.461035,"marketCap":379572960},{"date":"2024-05-03","current":-10.654895,"twenty":-12.497847,"median":-11.513206,"eighty":-10.478793,"marketCap":386825947},{"date":"2024-05-10","current":-10.802879,"twenty":-12.4592,"median":-11.360121,"eighty":-10.478793,"marketCap":392198529},{"date":"2024-05-17","current":-8.114957,"twenty":-12.377436,"median":-11.191128,"eighty":-10.431438,"marketCap":344382544},{"date":"2024-05-24","current":-7.443985,"twenty":-12.295701,"median":-11.079356,"eighty":-10.270134,"marketCap":315907856},{"date":"2024-05-31","current":-7.59948,"twenty":-12.254775,"median":-10.943138,"eighty":-9.999323,"marketCap":322506720},{"date":"2024-06-07","current":-7.453823,"twenty":-12.218885,"median":-10.773282,"eighty":-9.088414,"marketCap":316325341},{"date":"2024-06-14","current":-7.612146,"twenty":-12.153631,"median":-10.654895,"eighty":-8.114957,"marketCap":323044231},{"date":"2024-06-21","current":-6.997854,"twenty":-12.14058,"median":-10.580902,"eighty":-7.890353,"marketCap":296974938},{"date":"2024-06-28","current":-6.731872,"twenty":-12.125897,"median":-10.558705,"eighty":-7.854905,"marketCap":285687202},{"date":"2024-07-05","current":-7.35883,"twenty":-12.080219,"median":-10.514309,"eighty":-7.738804,"marketCap":312294007},{"date":"2024-07-12","current":-8.486086,"twenty":-11.912764,"median":-10.492111,"eighty":-7.738804,"marketCap":360132504},{"date":"2024-07-15","current":-8.840728,"twenty":-11.90384,"median":-10.492111,"eighty":-7.738804,"marketCap":375182817},{"date":"2024-08-02","current":-6.212575,"twenty":-11.894916,"median":-10.481012,"eighty":-7.674208,"marketCap":263649243},{"date":"2024-08-09","current":-5.762939,"twenty":-11.86488,"median":-10.440317,"eighty":-7.584281,"marketCap":244567596},{"date":"2024-08-16","current":-5.077305,"twenty":-11.842621,"median":-10.421819,"eighty":-7.439715,"marketCap":252875166},{"date":"2024-08-23","current":-5.770157,"twenty":-11.798049,"median":-10.270134,"eighty":-7.320833,"marketCap":287382652},{"date":"2024-08-30","current":-6.766131,"twenty":-11.747422,"median":-10.066655,"eighty":-7.023186,"marketCap":336987162},{"date":"2024-09-06","current":-6.885215,"twenty":-11.696849,"median":-9.985264,"eighty":-6.997854,"marketCap":342918136},{"date":"2024-09-13","current":-7.036776,"twenty":-11.629964,"median":-9.589405,"eighty":-7.005638,"marketCap":350466649},{"date":"2024-09-20","current":-7.269531,"twenty":-11.615282,"median":-8.800669,"eighty":-7.041657,"marketCap":362059007},{"date":"2024-09-27","current":-6.495486,"twenty":-11.576129,"median":-8.327763,"eighty":-6.997854,"marketCap":323507676},{"date":"2024-10-04","current":-5.51575,"twenty":-11.542663,"median":-8.073812,"eighty":-6.792939,"marketCap":274711934},{"date":"2024-10-11","current":-6.392641,"twenty":-11.505807,"median":-7.947789,"eighty":-6.506312,"marketCap":318385471},{"date":"2024-10-18","current":-7.724215,"twenty":-11.453451,"median":-7.863613,"eighty":-6.586066,"marketCap":384704544},{"date":"2024-10-25","current":-2.23553,"twenty":-11.361501,"median":-7.821648,"eighty":-6.506312,"marketCap":111340558},{"date":"2024-10-31","current":-2.181401,"twenty":-11.357822,"median":-7.776801,"eighty":-6.403467,"marketCap":108644661},{"date":"2024-11-08","current":-2.083968,"twenty":-11.223755,"median":-7.738804,"eighty":-6.212575,"marketCap":103792046},{"date":"2024-11-15","current":-2.159604,"twenty":-11.191128,"median":-7.724215,"eighty":-6.11117,"marketCap":124062772},{"date":"2024-11-22","current":-1.92017,"twenty":-11.14409,"median":-7.634377,"eighty":-5.98126,"marketCap":110307987},{"date":"2024-11-29","current":-2.070403,"twenty":-11.113816,"median":-7.615312,"eighty":-5.768005,"marketCap":118938440},{"date":"2024-12-06","current":-1.830969,"twenty":-11.06322,"median":-7.574148,"eighty":-5.648645,"marketCap":105183655},{"date":"2024-12-13","current":-1.798105,"twenty":-11.000259,"median":-7.504253,"eighty":-5.44863,"marketCap":103295743},{"date":"2024-12-20","current":-1.746462,"twenty":-10.916697,"median":-7.443985,"eighty":-5.07514,"marketCap":100329024},{"date":"2024-12-27","current":-2.075098,"twenty":-10.841355,"median":-7.436869,"eighty":-2.363274,"marketCap":119208142},{"date":"2025-01-03","current":-2.056319,"twenty":-10.79104,"median":-7.390494,"eighty":-2.255016,"marketCap":118129335},{"date":"2025-01-10","current":-2.070403,"twenty":-10.767363,"median":-7.35883,"eighty":-2.165554,"marketCap":118938440},{"date":"2025-01-17","current":-2.079793,"twenty":-10.725927,"median":-7.312287,"eighty":-2.141345,"marketCap":119477844},{"date":"2025-01-24","current":-2.272279,"twenty":-10.654895,"median":-7.277651,"eighty":-2.138097,"marketCap":130535613},{"date":"2025-01-31","current":-2.093877,"twenty":-10.603839,"median":-7.253293,"eighty":-2.122046,"marketCap":120286949},{"date":"2025-02-07","current":-1.854443,"twenty":-10.580902,"median":-7.17813,"eighty":-2.093877,"marketCap":106532163},{"date":"2025-02-14","current":-1.530502,"twenty":-10.558705,"median":-7.145034,"eighty":-2.075098,"marketCap":87922747},{"date":"2025-02-21","current":-1.464775,"twenty":-10.529107,"median":-7.061183,"eighty":-2.070403,"marketCap":84146924},{"date":"2025-02-28","current":-1.305152,"twenty":-10.515789,"median":-6.997854,"eighty":-2.041295,"marketCap":74977067},{"date":"2025-03-07","current":-1.854443,"twenty":-10.50839,"median":-6.933931,"eighty":-2.023455,"marketCap":106532163},{"date":"2025-03-14","current":-1.483554,"twenty":-10.495071,"median":-6.768,"eighty":-2.01289,"marketCap":85225730},{"date":"2025-03-21","current":-1.180996,"twenty":-10.492111,"median":-6.549615,"eighty":-1.993408,"marketCap":72549751},{"date":"2025-03-28","current":-1.062067,"twenty":-10.474353,"median":-6.422411,"eighty":-1.971812,"marketCap":65243830},{"date":"2025-04-04","current":-0.81528,"twenty":-10.458075,"median":-6.392641,"eighty":-1.92017,"marketCap":50083438},{"date":"2025-04-11","current":-0.903418,"twenty":-10.443277,"median":-6.253891,"eighty":-1.873222,"marketCap":55497864},{"date":"2025-04-17","current":-0.991556,"twenty":-10.440317,"median":-6.19297,"eighty":-1.833785,"marketCap":60912290},{"date":"2025-04-25","current":-1.004777,"twenty":-10.431438,"median":-6.11117,"eighty":-1.798105,"marketCap":61724454},{"date":"2025-05-02","current":-1.079695,"twenty":-10.421079,"median":-6.037568,"eighty":-1.742706,"marketCap":66326716},{"date":"2025-05-09","current":-0.965115,"twenty":-10.40924,"median":-5.975847,"eighty":-1.645994,"marketCap":59287962},{"date":"2025-05-16","current":-1.041186,"twenty":-10.323409,"median":-5.766106,"eighty":-1.583083,"marketCap":65785273},{"date":"2025-05-23","current":-1.255422,"twenty":-10.270134,"median":-5.686944,"eighty":-1.500455,"marketCap":79321337},{"date":"2025-05-30","current":-1.152589,"twenty":-10.199102,"median":-5.617282,"eighty":-1.480737,"marketCap":72824027},{"date":"2025-06-06","current":-1.019763,"twenty":-10.071835,"median":-5.469741,"eighty":-1.461958,"marketCap":64431667},{"date":"2025-06-13","current":-1.049756,"twenty":-10.02004,"median":-5.30697,"eighty":-1.408438,"marketCap":66326716},{"date":"2025-06-20","current":-0.972631,"twenty":-9.987484,"median":-5.077305,"eighty":-1.322054,"marketCap":61453732},{"date":"2025-06-27","current":-0.985485,"twenty":-9.980084,"median":-2.492642,"eighty":-1.263991,"marketCap":62265896},{"date":"2025-07-03","current":-1.006909,"twenty":-9.974165,"median":-2.341082,"eighty":-1.221144,"marketCap":63619503},{"date":"2025-07-11","current":-1.105457,"twenty":-9.589405,"median":-2.272279,"eighty":-1.163435,"marketCap":69846092},{"date":"2025-07-18","current":-1.233999,"twenty":-8.963166,"median":-2.213594,"eighty":-1.13545,"marketCap":77967731},{"date":"2025-07-25","current":-1.319693,"twenty":-8.840728,"median":-2.178383,"eighty":-1.148304,"marketCap":83382157},{"date":"2025-08-01","current":-1.315408,"twenty":-8.760609,"median":-2.161951,"eighty":-1.152589,"marketCap":83111436},{"date":"2025-08-08","current":-1.311123,"twenty":-8.486086,"median":-2.154336,"eighty":-1.163435,"marketCap":82840714},{"date":"2025-08-15","current":-1.302504,"twenty":-8.327763,"median":-2.124393,"eighty":-1.163435,"marketCap":84479082},{"date":"2025-08-22","current":-1.498714,"twenty":-8.182106,"median":-2.122046,"eighty":-1.165443,"marketCap":97205098},{"date":"2025-08-29","current":-1.590557,"twenty":-8.114957,"median":-2.098572,"eighty":-1.169728,"marketCap":103161956},{"date":"2025-09-05","current":-1.465317,"twenty":-8.049126,"median":-2.084227,"eighty":-1.178742,"marketCap":95038967},{"date":"2025-09-12","current":-1.640654,"twenty":-7.979964,"median":-2.075098,"eighty":-1.18912,"marketCap":106411151},{"date":"2025-09-19","current":-1.715798,"twenty":-7.951589,"median":-2.070403,"eighty":-1.198007,"marketCap":111284945},{"date":"2025-09-26","current":-1.586383,"twenty":-7.904286,"median":-2.056319,"eighty":-1.216859,"marketCap":102891190},{"date":"2025-10-03","current":-1.841039,"twenty":-7.881184,"median":-2.039887,"eighty":-1.228,"marketCap":119407933},{"date":"2025-10-10","current":-2.513164,"twenty":-7.867586,"median":-2.056319,"eighty":-1.233142,"marketCap":163001306},{"date":"2025-10-17","current":-2.454718,"twenty":-7.85227,"median":-2.070403,"eighty":-1.244282,"marketCap":159210578},{"date":"2025-10-24","current":-4.667305,"twenty":-7.827138,"median":-2.075098,"eighty":-1.253708,"marketCap":302716712},{"date":"2025-10-31","current":-5.978158,"twenty":-7.812987,"median":-2.084227,"eighty":-1.2897,"marketCap":387737327},{"date":"2025-11-07","current":-4.646431,"twenty":-7.783605,"median":-2.103267,"eighty":-1.301657,"marketCap":301362880},{"date":"2025-11-14","current":-4.738274,"twenty":-7.773873,"median":-2.122046,"eighty":-1.304622,"marketCap":307319739},{"date":"2025-11-21","current":-7.060871,"twenty":-7.758215,"median":-2.12674,"eighty":-1.306199,"marketCap":439588640},{"date":"2025-11-28","current":-6.91117,"twenty":-7.745076,"median":-2.154336,"eighty":-1.306688,"marketCap":430268739},{"date":"2025-12-05","current":-6.67664,"twenty":-7.738804,"median":-2.161951,"eighty":-1.306839,"marketCap":415667562},{"date":"2025-12-12","current":-7.325342,"twenty":-7.736546,"median":-2.178383,"eighty":-1.309247,"marketCap":456053797},{"date":"2025-12-19","current":-9.705579,"twenty":-7.761946,"median":-2.213594,"eighty":-1.311015,"marketCap":604240215},{"date":"2025-12-26","current":-9.920149,"twenty":-7.817318,"median":-2.253904,"eighty":-1.311123,"marketCap":617598739},{"date":"2026-01-02","current":-8.882226,"twenty":-7.875492,"median":-2.303191,"eighty":-1.311123,"marketCap":552980763},{"date":"2026-01-09","current":-7.929133,"twenty":-7.944058,"median":-2.354526,"eighty":-1.311807,"marketCap":493644063},{"date":"2026-01-16","current":-8.493005,"twenty":-8.098499,"median":-2.410079,"eighty":-1.314542,"marketCap":528749021},{"date":"2026-01-23","current":-8.572845,"twenty":-8.233524,"median":-2.467243,"eighty":-1.314542,"marketCap":533719635},{"date":"2026-01-30","current":-7.644703,"twenty":-8.248494,"median":-2.550736,"eighty":-1.315408,"marketCap":475936252},{"date":"2026-02-06","current":-7.040911,"twenty":-8.233524,"median":-2.675047,"eighty":-1.315408,"marketCap":438345986},{"date":"2026-02-13","current":-8.203584,"twenty":-8.278435,"median":-4.258185,"eighty":-1.315408,"marketCap":510730547},{"date":"2026-02-20","current":-9.730529,"twenty":-8.329873,"median":-4.59216,"eighty":-1.315408,"marketCap":605793532},{"date":"2026-02-27","current":-9.625739,"twenty":-8.433125,"median":-4.619295,"eighty":-1.315408,"marketCap":599269602},{"date":"2026-03-06","current":-10.26945,"twenty":-8.504981,"median":-4.688178,"eighty":-1.318836,"marketCap":639345174},{"date":"2026-03-13","current":-11.092803,"twenty":-8.596797,"median":-4.780021,"eighty":-1.319693,"marketCap":690604627},{"date":"2026-03-20","current":-10.997993,"twenty":-8.80207,"median":-5.077305,"eighty":-1.323121,"marketCap":684702023},{"date":"2026-03-27","current":-10.5175,"twenty":-8.978914,"median":-5.159821,"eighty":-1.327405,"marketCap":665105643},{"date":"2026-04-02","current":-11.825873,"twenty":-9.157675,"median":-5.286907,"eighty":-1.342565,"marketCap":747844529},{"date":"2026-04-10","current":-11.315658,"twenty":-9.59795,"median":-5.418318,"eighty":-1.358364,"marketCap":715579558},{"date":"2026-04-17","current":-14.44502,"twenty":-9.715559,"median":-5.499511,"eighty":-1.373177,"marketCap":913474169},{"date":"2026-04-24","current":-14.251015,"twenty":-9.940109,"median":-5.617282,"eighty":-1.380269,"marketCap":901205714},{"date":"2026-05-01","current":-14.2233,"twenty":-9.993374,"median":-5.686437,"eighty":-1.40625,"marketCap":899453077},{"date":"2026-05-08","current":-13.341966,"twenty":-10.092797,"median":-5.762939,"eighty":-1.428579,"marketCap":843719235},{"date":"2026-05-15","current":-11.128225,"twenty":-10.269724,"median":-5.815711,"eighty":-1.431919,"marketCap":826893924},{"date":"2026-05-22","current":-10.161169,"twenty":-10.270134,"median":-5.928061,"eighty":-1.443182,"marketCap":755035825},{"date":"2026-05-29","current":-9.538479,"twenty":-10.26986,"median":-5.978158,"eighty":-1.454447,"marketCap":708766220},{"date":"2026-06-05","current":-9.448849,"twenty":-10.241369,"median":-6.015388,"eighty":-1.46008,"marketCap":702106201},{"date":"2026-06-12","current":-10.121163,"twenty":-10.184016,"median":-6.089518,"eighty":-1.46008,"marketCap":752063134},{"date":"2026-06-18","current":-10.291187,"twenty":-10.191631,"median":-6.176125,"eighty":-1.461019,"marketCap":764696952},{"date":"2026-06-26","current":-11.948923,"twenty":-10.281083,"median":-6.203076,"eighty":-1.464883,"marketCap":887876682},{"date":"2026-07-02","current":-11.778899,"twenty":-10.355847,"median":-6.327685,"eighty":-1.465317,"marketCap":875242863},{"date":"2026-07-10","current":-13.05408,"twenty":-10.419151,"median":-6.392641,"eighty":-1.474164,"marketCap":969996501},{"date":"2026-07-17","current":-14.296657,"twenty":-10.441725,"median":-6.422411,"eighty":-1.474164,"marketCap":1062327376},{"date":"2026-07-24","current":-14.045563,"twenty":-10.492111,"median":-6.506979,"eighty":-1.478859,"marketCap":1043669595},{"date":"2026-07-31","current":-14.976703,"twenty":-10.518342,"median":-6.61177,"eighty":-1.482615,"marketCap":1112858864},{"date":"2026-08-07","current":-14.893005,"twenty":-10.61405,"median":-6.65169,"eighty":-1.485663,"marketCap":1106639604},{"date":"2026-08-14","current":-15.04689,"twenty":-10.749604,"median":-6.68163,"eighty":-1.487837,"marketCap":1267519959},{"date":"2026-08-21","current":-15.955294,"twenty":-10.831771,"median":-6.749002,"eighty":-1.49576,"marketCap":1344042062}],"updateTime":1787642040264},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ANRO\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2629466036","title":"Alto Neuroscience Inc - Topline Data Expected in Second Half of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2629466036","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629466036?lang=en_us&edition=fundamental","pubTime":"2026-04-21 20:03","pubTimestamp":1776772980,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nTUADZSRF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629460036","title":"Alto Neuroscience Initiates Phase 2B Trial of Alto-207 in Treatment-Resistant Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2629460036","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629460036?lang=en_us&edition=fundamental","pubTime":"2026-04-21 20:03","pubTimestamp":1776772980,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nTUADZSRF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626148685","title":"Alto Neuroscience Files for Resale of Shares by Selling Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2626148685","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626148685?lang=en_us&edition=fundamental","pubTime":"2026-04-11 04:26","pubTimestamp":1775852789,"startTime":"0","endTime":"0","summary":"Alto Neuroscience  filed a registration statement late Friday with the US Securities and Exchange Commission for the resale of up to 6 million of its shares by certain shareholders from time to time.The company will not receive any proceeds from the sale of these shares, according to the filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626148855","title":"BRIEF-Alto Neuroscience - Proposed Resale Of Up To 6 Million Shares Of Common Stock By Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2626148855","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626148855?lang=en_us&edition=fundamental","pubTime":"2026-04-11 04:17","pubTimestamp":1775852249,"startTime":"0","endTime":"0","summary":"BRIEF-Alto Neuroscience - Proposed Resale Of Up To 6 Million Shares Of Common Stock By Selling Stockholders - SEC FilingApril 10  - Alto Neuroscience Inc ANRO.N:ALTO NEUROSCIENCE - PROPOSED RESALE OF UP TO 6 MILLION SHARES OF COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILINGSource text: []Further company coverage: ANRO.N ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nFWN40T0SL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626110100","title":"Alto Neuroscience - Proposed Resale of up to 6 Mln Shares of Common Stock by Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2626110100","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626110100?lang=en_us&edition=fundamental","pubTime":"2026-04-11 04:02","pubTimestamp":1775851342,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nFWN40T0SL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANRO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625647294","title":"Analysts Conflicted on These Healthcare Names: Merck & Company (MRK) and Alto Neuroscience, Inc. (ANRO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2625647294","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625647294?lang=en_us&edition=fundamental","pubTime":"2026-04-06 00:30","pubTimestamp":1775406608,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Merck & Company (MRK) and Alto Neuroscience, Inc. (ANRO). Merck &...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-merck-company-mrk-and-alto-neuroscience-inc-anro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-merck-company-mrk-and-alto-neuroscience-inc-anro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1066051498.USD","LU1201861249.SGD","IE0009355771.USD","LU1037948541.HKD","LU1989771016.USD","SG9999015358.SGD","LU0965508806.USD","LU0058720904.USD","LU0211331839.USD","BK4581","LU1989772840.SGD","SG9999014559.SGD","LU0861579265.USD","LU0029874061.USD","SG9999002232.USD","IE00BJT1NW94.SGD","LU1989772923.USD","LU1571399168.USD","IE00BSNM7G36.USD","LU2324357040.USD","LU0289739699.SGD","IE000M9KFDE8.USD","IE00B2B36J28.USD","IE00B1BXHZ80.USD","LU1066051811.HKD","LU0985320562.USD","LABU","LU2461242641.AUD","LU0942090050.USD","LU0238689110.USD","LU0965509283.SGD","LU2089984988.USD","BK4007","LU1066051225.USD","LU2106854487.HKD","LU1035773651.USD","SGXZ57979304.SGD","BK4516","LU0477156953.USD","LU1929549753.HKD","SG9999001176.USD","LU1430594728.SGD","LU1699723380.USD","LU0203345920.USD","LU0128526141.USD","LU1037948897.HKD","IE00BJJMRZ35.SGD","LU1116320901.HKD","LU0965509010.AUD","LU0006306889.USD","LU0234572021.USD","IE0002141913.USD","IE00BN8TJ469.HKD","LU0965509101.SGD","LU0208291251.USD","SG9999001440.SGD","IE00BFTCPJ56.SGD","LU1069347547.HKD","BK4585","SG9999014542.SGD","LU1934455277.USD","IE00BLSP4239.USD","LU2468319806.SGD","IE00BBT3K403.USD","LU1066053197.SGD","BK4588","LU1974910355.USD","LU0070302665.USD","BK4559","LU0265550946.USD","LU0648001328.SGD","IE00BLSP4452.SGD","LU0868494708.USD","LU1917777945.USD","ANRO","SG9999013999.USD","LU2361044865.SGD","LU2360032135.SGD","LU1023059063.AUD","LU2125154778.USD","LU0320765646.SGD","SG9999015341.SGD","LU1934455194.USD","BK4550","LU0106261372.USD","BK4137","LU1983299246.USD","LU0130517989.USD","LU0098860793.USD","LU0203347892.USD","LU2361045086.USD","LU0266013472.USD","LU2023250504.SGD","LU1291159041.SGD","LU1941712348.USD","LU0320765489.SGD","LU0432979614.USD","LU0868494617.USD","XBI","SG9999014575.USD","MRK","LU1116320737.USD","LU1093756325.SGD","BK4534","LU1934455863.HKD","LU1093756168.USD","LU2023250843.SGD","SG9999014567.USD","LU1061106388.HKD","BK4533","SG9999001176.SGD","LU2361044949.HKD","LU2112291526.USD","LU2125154935.USD","LU1162221912.USD","LU1057294990.SGD","SG9999002224.SGD","LU1585245621.USD","LU0130102774.USD","LU1941712264.USD","LU0980610538.SGD","IE00B4R5TH58.HKD","LU0122379950.USD","LU0265550359.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624681885","title":"Update: Alto Neuroscience Shares Fall After Phase 2 Trial of ALTO-101 Yields Statistically Insignificant Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2624681885","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624681885?lang=en_us&edition=fundamental","pubTime":"2026-04-03 02:36","pubTimestamp":1775154990,"startTime":"0","endTime":"0","summary":"(Updates with the latest stock movement in the headline and the first paragraph.)Alto Neuroscience (ANRO) shares fell 3.1% on Thursday, a day after the company said topline data from its Phase 2 proof","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ANRO","BK4138","BK4007","ALTO","BK4109"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624130501","title":"Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Alto Neuroscience, Inc. (ANRO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624130501","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624130501?lang=en_us&edition=fundamental","pubTime":"2026-04-02 20:50","pubTimestamp":1775134219,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Boston Scientific (BSX) and Alto Neuroscience, Inc. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-boston-scientific-bsx-and-alto-neuroscience-inc-anro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-boston-scientific-bsx-and-alto-neuroscience-inc-anro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1153585028.USD","LU0528227936.USD","BK4585","LU0128526141.USD","IE00B2B36J28.USD","LU2087625088.SGD","LU2244417387.USD","ANRO","SGXZ57979304.SGD","LU2362541273.HKD","LU0823416689.USD","LU0077335932.USD","LU1061106388.HKD","HCSG","LU0029874061.USD","LU1548497426.USD","LU1791710400.SGD","XLV","XBI","LU0345769631.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0048584097.USD","LU0882574055.USD","LU0432979614.USD","LU1989771016.USD","SG9999013999.USD","LU1989772840.SGD","LU1989764748.USD","BK4504","BK4082","IE0009355771.USD","LU0266013472.USD","LU1366192091.USD","IE0002141913.USD","BSX","LU0823417653.USD","LU0353189763.USD","LU0345769128.USD","BK4581","LU0114720955.EUR","LU2506952170.USD","SG9999001176.SGD","LU2506951875.HKD","BK4007","LU1720051108.HKD","LU1720051017.SGD","LU1023059063.AUD","LU1983299246.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624509583","title":"Alto Neuroscience Is Maintained at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2624509583","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624509583?lang=en_us&edition=fundamental","pubTime":"2026-04-02 20:22","pubTimestamp":1775132520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ANRO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 02, 2026 08:22 ET (12:22 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624098335","title":"Alto Neuroscience, Immunovant And Other Big Stocks Moving Lower In Thursday's Pre-Market Session","url":"https://stock-news.laohu8.com/highlight/detail?id=2624098335","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624098335?lang=en_us&edition=fundamental","pubTime":"2026-04-02 20:02","pubTimestamp":1775131320,"startTime":"0","endTime":"0","summary":"Dow futures down 400 points, Alto Neuroscience shares dip 13.6% after Phase 2 trial results, other stocks also falling in pre-market trading.","market":"nz","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/02/Display-Of-Stock-Market-Quotes.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/02/Display-Of-Stock-Market-Quotes.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/26/04/51622047/alto-neuroscience-immunovant-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/04/51622047/alto-neuroscience-immunovant-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624506828","title":"Wedbush Cuts Price Target on Alto Neuroscience to $21 From $22, Keeps Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2624506828","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624506828?lang=en_us&edition=fundamental","pubTime":"2026-04-02 19:56","pubTimestamp":1775131017,"startTime":"0","endTime":"0","summary":"Alto Neuroscience (ANRO) has an average rating of buy and mean price target of $35.80, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624950661","title":"Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO) and Innovative Eyewear, Inc. (LUCY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624950661","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624950661?lang=en_us&edition=fundamental","pubTime":"2026-04-02 19:51","pubTimestamp":1775130668,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alto Neuroscience, Inc. (ANRO) and Innovative Eyew...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alto-neuroscience-inc-anro-and-innovative-eyewear-inc-lucy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alto-neuroscience-inc-anro-and-innovative-eyewear-inc-lucy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4581","ANRO","XBI","BK4198","LABU","BK4585","LU0029874061.USD","LUCY","BK4588","XLV","HCSG","BK4007","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624575278","title":"U.S. RESEARCH ROUNDUP-Doordash, Phillips 66, United Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2624575278","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624575278?lang=en_us&edition=fundamental","pubTime":"2026-04-02 15:21","pubTimestamp":1775114493,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Doordash, Phillips 66, United TherapeuticsApril 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nL4N40L0JF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAH","ANRO","BHVN","CQP","GOOGL","LNG","GGLL","AROC","GD","BAC","GOOY","GOU","DASH","DK","GE","CSL","DCO","APLS","BETA","BA","GOOP","GOOX","XOMZ","CVX","ALAB","FBK","CVI","CEG","COP","FBIN","BYND","STZ","AMZN","USAW.SI","BJRI","BOH","CAG","XOM","GENK","DASX","CTRE","GOOW","CAVA","BARK","GPN","CACI","CW","AZYY","DIN","CFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624521273","title":"Alto Neuroscience Inc : Baird Cuts Target Price to $38 From $41","url":"https://stock-news.laohu8.com/highlight/detail?id=2624521273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624521273?lang=en_us&edition=fundamental","pubTime":"2026-04-02 11:12","pubTimestamp":1775099571,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nFWN40K0YR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANRO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624525346","title":"Chardan Capital Remains a Buy on Alto Neuroscience, Inc. (ANRO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624525346","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624525346?lang=en_us&edition=fundamental","pubTime":"2026-04-02 08:48","pubTimestamp":1775090914,"startTime":"0","endTime":"0","summary":"Chardan Capital analyst Keay Nakae maintained a Buy rating on Alto Neuroscience, Inc. yesterday and set a price target of $30.00. Nakae covers the ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/chardan-capital-remains-a-buy-on-alto-neuroscience-inc-anro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/chardan-capital-remains-a-buy-on-alto-neuroscience-inc-anro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANRO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624154036","title":"Stocks to Watch: Franklin Covey, Penguin Solutions, Alto Neuroscience","url":"https://stock-news.laohu8.com/highlight/detail?id=2624154036","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624154036?lang=en_us&edition=fundamental","pubTime":"2026-04-02 07:16","pubTimestamp":1775085360,"startTime":"0","endTime":"0","summary":"Franklin Covey posted higher-than-expected results in its fiscal second quarter. The stock rose 12%, to $18.14, in after-hours trading Wednesday.Penguin Solutions raised its full-year outlook. Shares gained 10%, to $20.10, after the bell.Alto Neuroscience missed the primary endpoint in a trial studying a drug to treat schizophrenia. The stock fell 8%, to $21.50.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B66KJ199.SGD","IE00B19Z4B17.USD","BK4123","FC","IE0031619046.USD","BK4141","BK4007","IE00B7SZL793.SGD","ANRO","PENG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624424785","title":"Alto Shifts Focus to ALTO-207 After ALTO-101 Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2624424785","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624424785?lang=en_us&edition=fundamental","pubTime":"2026-04-02 05:48","pubTimestamp":1775080082,"startTime":"0","endTime":"0","summary":"Alto Neuroscience, Inc. ( ($ANRO) ) has shared an announcement. On April 1, 2026, Alto Neuroscience reported topline Phase 2 proof-of-concept data ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alto-shifts-focus-to-alto-207-after-alto-101-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alto-shifts-focus-to-alto-207-after-alto-101-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4109","ANRO","BK4007","BK4138","ALTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624542442","title":"Pipeline Strength and Key Late-Stage Assets Drive Upside in Alto Neuroscience Despite ALTO-101 Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2624542442","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624542442?lang=en_us&edition=fundamental","pubTime":"2026-04-02 05:45","pubTimestamp":1775079925,"startTime":"0","endTime":"0","summary":"William Blair analyst Myles Minter has reiterated their bullish stance on ANRO stock, giving a Buy rating on March 19. Myles Minter has given his B...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/pipeline-strength-and-key-late-stage-assets-drive-upside-in-alto-neuroscience-despite-alto-101-setback-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/pipeline-strength-and-key-late-stage-assets-drive-upside-in-alto-neuroscience-despite-alto-101-setback-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANRO","SSI","ALTO","BK4109","BK4138","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624444915","title":"BRIEF-Alto Neuroscience Reports Topline Data From Phase 2 Proof-Of-Concept Study Of Alto-101 And Highlights Pipeline Advancements","url":"https://stock-news.laohu8.com/highlight/detail?id=2624444915","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624444915?lang=en_us&edition=fundamental","pubTime":"2026-04-02 05:18","pubTimestamp":1775078308,"startTime":"0","endTime":"0","summary":"BRIEF-Alto Neuroscience Reports Topline Data From Phase 2 Proof-Of-Concept Study Of Alto-101 And Highlights Pipeline AdvancementsApril 1 (Reuters) - Alto Neuroscience Inc ANRO.N:ALTO NEUROSCIENCE REPO","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nFWN40K14F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANRO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624541760","title":"Alto Neuroscience publishes investor presentation on biomarker-driven precision psychiatry pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2624541760","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624541760?lang=en_us&edition=fundamental","pubTime":"2026-04-02 04:49","pubTimestamp":1775076546,"startTime":"0","endTime":"0","summary":"Alto Neuroscience outlined strategy to develop biomarker-guided medicines for psychiatric and neurologic disorders, aiming to improve response rates by stratifying patients.ALTO-208 in Phase 2b targets bipolar depression, with topline data expected in 2H 2026.ALTO-207 for treatment-resistant depression is slated to start Phase 2b in 1H 2026 with topline data expected 2H 2027.Company also flagged four late-stage data readouts over next three years, citing more than 1,000 patients dosed across studies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alto Neuroscience Inc. published the original content used to generate this news brief on April 01, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL3qjKh4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANRO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":110,"code":"91000000","status":"200"}]}}